GAUDIUMIVF logo

Gaudium IVF and Women Health Limited

GAUDIUMIVF·NSE·
₹101.70▼ -1.08 (-1.05%)
Market Cap739.88 Cr
PE Ratio30.27
Volume91,932
Day High - Low104.00 - 101.00
52W High-Low163.18 - 69.18

Gaudium IVF and Women Health Limited (GAUDIUMIVF): company summary

The company's annual revenue rose 47.0% to ₹104 crore, while annual net profit increased 28.7% to ₹24 crore.

Gaudium IVF and Women Health Limited (GAUDIUMIVF) is a micro-cap Healthcare company valued at ₹740 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move
Gaudium IVF and Women Health Limited last traded at ₹101.7, modestly down 1.05% on the day.
Recent developments
On 2026-07-15, the company announced the commencement of commercial operations at its new IVF Centre/Hub in South Extension, New Delhi, marking a key expansion step for its services.
Financial performance
The company's annual revenue rose 47.0% to ₹104 crore, while annual net profit increased 28.7% to ₹24 crore. However, the net profit margin narrowed 3.3 percentage points to 23.4%, and the latest quarter saw net profit fall 42.0% to ₹2 crore despite revenue rising 9.1% to ₹19 crore.
Valuation multiples
The stock trades at 30.3 times earnings, broadly in line with the Healthcare median of 32.0, 5.47 times book value.
Things to watch
The company's net profit margin has declined, and the latest quarter's net profit dropped significantly. The stock is 32.9% below its 52-week high, and the company has not paid dividends despite reporting profits.
Where it stands
The company has seen strong revenue growth over the past three years, but its net profit margin has narrowed. The latest quarter's net profit fell sharply, and the stock is trading below its 52-week high. The company's promoter holds 71.29% of the shares.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
16.06%
Strong
P/E
30.27x
Fair
Debt / Equity
0.16
Low
Industry
Healthcare
Healthcare Service Provider
Overall View
Mixed

Price performance

Day₹101.00
₹104.00
52W₹69.18
₹163.18
DocStoX take

Supported by risk (7.5) and growth (7.2), but held back by valuation (2.2). Risk looks strong at 7.5, but that is offset by valuation at 2.2 and momentum at 2.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.6
/10
Fair
Quality
Solid
ROE 16.1%
Valuation
Expensive
P/E 30.3×
Growth
Steady
Revenue +33.4% 3Y CAGR
Risk
Low risk
D/E 0.16
Momentum
Weak
35% of 52-week range

At a glance

Market Cap
₹740 Cr
52W High / Low
₹163 / ₹69
Dividend Yield
0.00%
Promoter Holding
71.29%
EPS (TTM)
₹3.36
Book Value
₹20.92

Key highlights

  • Revenue compounding 33% a year
  • Low leverage — D/E 0.16
  • Profitable in all of the last 5 years
  • Valuation is weak (2.2/10)
  • Small ₹740 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

Gaudium IVF and Women Health Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.